Article Details

Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R ...

Retrieved on: 2021-01-26 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Rhythm Pharmaceuticals Announces Positive Data with Setmelanotide in Additional MC4R .... View article details on hiswai:

Excerpt

Data from the SRC1 and SH2B1 cohorts were based on an interim analysis of patients who completed 12 weeks of therapy. This analysis did not ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up